Advent Life Sciences
VC
2006
$92 000 M
London, England, United Kingdom
Profile
Advent Life Sciences is a venture capital firm based in London, founded in 2006. The firm specializes in life sciences investments with a focus on building innovative businesses in the UK, Europe, and the USA. The team comprises experienced entrepreneurs and investors who have a strong track record in turning breakthrough science into approved medicines and medical products. This hands-on team supports portfolio companies closely and aligns with management teams to realize their visions.
Advent Life Sciences invests in early and mid-stage companies, with particular interest in new drug discovery, med tech, enabling technologies, and vaccines. The firm focuses on seed and Series A stages with a geographical interest in trans-Atlantic opportunities. Advent's portfolio boasts companies that have brought 15 innovative medicines and products to market since its inception.
Notable investments include Pheno Therapeutics - multiple sclerosis therapies, F2G - antifungal treatments, Amphista Therapeutics - cancer treatments, and other leading edge life sciences companies. These significant investments reflect the firm's strength in identifying and supporting high-potential ventures in the life sciences sector.
Industry
Advent Life Sciences Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Advent Life Sciences Fund I
|
Venture Capital (VC)
|
Healthcare Services
Medical Devices
MedTech
Technology
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$95 M
|
December 2010
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.